Form 8-K - Current report:
SEC Accession No. 0001193125-25-047726
Filing Date
2025-03-06
Accepted
2025-03-06 06:03:44
Documents
21
Period of Report
2025-03-06
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d897411d8k.htm   iXBRL 8-K 39451
2 EX-99.1 d897411dex991.htm EX-99.1 29748
6 GRAPHIC g897411ex99_1p1g1.jpg GRAPHIC 242789
7 GRAPHIC g897411ex99_1p2g1.jpg GRAPHIC 464233
8 GRAPHIC g897411ex99_1p3g1.jpg GRAPHIC 245504
9 GRAPHIC g897411ex99_1p4g1.jpg GRAPHIC 323354
10 GRAPHIC g897411ex99_1p5g1.jpg GRAPHIC 281280
11 GRAPHIC g897411ex99_1p6g1.jpg GRAPHIC 331686
12 GRAPHIC g897411ex99_1p7g1.jpg GRAPHIC 490567
  Complete submission text file 0001193125-25-047726.txt   3486775

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA slrn-20250306.xsd EX-101.SCH 2840
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE slrn-20250306_lab.xml EX-101.LAB 17977
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE slrn-20250306_pre.xml EX-101.PRE 11251
24 EXTRACTED XBRL INSTANCE DOCUMENT d897411d8k_htm.xml XML 3677
Mailing Address 4149 LIBERTY CANYON RD. AGOURA HILLS CA 91301
Business Address 4149 LIBERTY CANYON RD. AGOURA HILLS CA 91301 805-456-4393
ACELYRIN, Inc. (Filer) CIK: 0001962918 (see all company filings)

EIN.: 852406735 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41696 | Film No.: 25713496
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)